APA (7th ed.) Citation

Wang, Y., Jia, Q., Liu, H., Li, Z., & Ma, Y. (2025). RPL29 as a radiotherapy-sensitive prognostic biomarker in multiple myeloma. World Journal of Surgical Oncology, 23(1), 1. https://doi.org/10.1186/s12957-025-04038-z

Chicago Style (17th ed.) Citation

Wang, Yihua, Qi Jia, Hongxiu Liu, Zhihua Li, and Yanping Ma. "RPL29 as a Radiotherapy-sensitive Prognostic Biomarker in Multiple Myeloma." World Journal of Surgical Oncology 23, no. 1 (2025): 1. https://doi.org/10.1186/s12957-025-04038-z.

MLA (9th ed.) Citation

Wang, Yihua, et al. "RPL29 as a Radiotherapy-sensitive Prognostic Biomarker in Multiple Myeloma." World Journal of Surgical Oncology, vol. 23, no. 1, 2025, p. 1, https://doi.org/10.1186/s12957-025-04038-z.